SEC Company Response from VIVOS INC (RDGL) (CIK 0001449349) (RDGL) — Nov 15, 2011
VIVOS INC (RDGL) (CIK 0001449349)
Date: Nov. 15, 2011 · CIK: 0001449349 · Accession: 0001199835-11-000751
AI Filing Summary & Sentiment
Reasoning
Letter
Via EDGAR Division of Corporation Finance Filed March 1, 2011 Form 10-Q for the Fiscal Quarter ended June 30, 2011 Filed August 4, 2011 File No. 0-53497
Dear Mr. Decker:
Confirming my voicemail message today to Mr. Slivka, our client Advanced Medical Isotope Corporation hereby requests additional time to respond to the November 1, 2011 comment letter relating to the filings listed above and hereby advises the staff that it expects to respond to that comment letter by Friday, December 2, 2011.
Any questions regarding this request can be directed to the undersigned by telephone to 206-386-7603 or by fax to 206-386-7500.
Very truly yours,
/s/ L. John Stevenson, Jr.
Show Raw Text
CORRESP
1
filename1.htm
admd_corresp.htm
STOEL RIVES LLP
Attorneys at law
600 University Street, Suite 3600
Seattle, WA 98101
main 206.624.0900
fax 206.386.7500
www.stoel.com
November 15, 2011
Via EDGAR
Mr. Rufus Decker
Accounting Branch Chief
Division of Corporation Finance
U.S. Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Re:
Advanced Medical Isotope Corporation
Form 10-K for the Fiscal Year ended December 31, 2010
Filed March 1, 2011
Form 10-Q for the Fiscal Quarter ended June 30, 2011
Filed August 4, 2011
File No. 0-53497
Dear Mr. Decker:
Confirming my voicemail message today to Mr. Slivka, our client Advanced Medical Isotope Corporation hereby requests additional time to respond to the November 1, 2011 comment letter relating to the filings listed above and hereby advises the staff that it expects to respond to that comment letter by Friday, December 2, 2011.
Any questions regarding this request can be directed to the undersigned by telephone to 206-386-7603 or by fax to 206-386-7500.
Very truly yours,
/s/ L. John Stevenson, Jr.
L. John Stevenson, Jr.
cc:
Mr. Edward M. Kelly, Senior Counsel, Securities and Exchange Commission
Mr. Craig E. Slivka, Special Counsel, Securities and Exchange Commission
Mr. Jeffrey Gordon, Staff Accountant, Securities and Exchange Commission
Mr. James C. Katzaroff, Chief Executive Officer
Mr. L. Bruce Jolliff, Chief Financial Officer